Chris MacDonald

Chris MacDonald

InvestorPlace Contributor

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

FEG Token Price Predictions: Where Will the Red-Hot FEG Crypto Go Next?

By Chris MacDonald, InvestorPlace Contributor

Today, interest in FEG Token price predictions is surging, following a speculative surge in interest among micro cap tokens.

Tron Price Predictions: Where Will the TRX Crypto Go Amid DAO Restructuring?

By Chris MacDonald, InvestorPlace Contributor

Today, interest around the TRX crypto and Tron price predictions is surging, following the news this project is shifting to a DAO structure.

BLINU Crypto Prices Jump 20% as Baby Lambo Inu Celebrates BitMart Listing

By Chris MacDonald, InvestorPlace Contributor

Investors looking at the more speculative side of the crypto market are watching Baby Lambo Inu and the BLINU crypto today as it surges.

BDSI Stock Alert: The Deal Sending Little-Known BioDelivery Skyrocketing Today

By Chris MacDonald, InvestorPlace Contributor

Today, a big takeover announcement has sent shares of BioDelivery and BDSI stock soaring more than 50% on investor enthusiasm for this deal.

Short Squeeze Stocks: ARDS, BBIG and 3 Others Experts Think Are Ready to Pop

By Chris MacDonald, InvestorPlace Contributor

As far as short squeeze stocks go, these five companies top the list in terms of both short interest and borrow fee rates right now.

Is MRNA Stock a Buy Following 12% Plunge? 4 Analysts Weigh In.

By Chris MacDonald, InvestorPlace Contributor

Here's where the expert Wall Street analysts think Moderna and MRNA stock could be headed from here, following recent weakness.

7 Defensive Growth Stocks to Buy for February

By Chris MacDonald, InvestorPlace Contributor

These seven top defensive growth stocks are among the best options for investors looking for growth, but with a risk-off perspective.

7 Top Cryptos to Buy at a 50% Discount Right Now

By Chris MacDonald, InvestorPlace Contributor

These seven top cryptos could be among the best picks for long-term investors to consider amid this significant dip in the crypto market.

BABYMUSK Crypto Spikes 33% as Investors Bark for the New Baby Musk Meme Coin

By Chris MacDonald, InvestorPlace Contributor

Today, the world has yet another meme token to look at, with the initial coin offering of the BABYMUSK crypto grabbing investor attention.

Is PTON Stock a Buy Right Now? 2 Analysts Weigh In on Peloton Price Predictions.

By Chris MacDonald, InvestorPlace Contributor

A range of impressive PTON stock price targets are being issued by analysts looking at this company's prospects moving forward.

Load More